Jul 1, 2022 | BioForward Member News
A Madison-based company called FluGen has begun a new study of its flu vaccine in older adults. FluGen aims to improve on currently available flu vaccine options, which have “shown only modest efficacy” in most flu seasons, the company said in a release. A...
Jun 30, 2022 | BioForward Member News
French drugmaker Sanofi on Monday said the COVID-19 vaccine candidate it has developed jointly with GSK in two trials showed a potential to protect against the virus’s main variants of concern, including the Omicron BA.1 and BA.2 strains, when used as a booster jab....
Jun 29, 2022 | BioForward Member News
At the Steenbock Symposium on June 7 and 8, 2022, the University of Wisconsin–Madison Department of Biochemistry opened its doors in celebration of two new research centers that bring to campus advanced biomolecular imaging technology called cryo-electron microscopy....
Jun 28, 2022 | BioForward Member News
The finding has implications for future treatment of retinal diseases that cause blindness, including age-related macular degeneration and rare diseases such as retinitis pigmentosa, Usher syndrome, Stargardt disease and Best disease. People living with these...
Jun 27, 2022 | BioForward Member News
U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week. The Food and Drug Administration’s action follows its advisory panel’s unanimous recommendation for...
Jun 24, 2022 | BioForward Member News
U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week. The Food and Drug Administration’s action follows its advisory panel’s unanimous recommendation for...